An Open-label Multicenter Phase 2 Trial of Telacebec for Adults with Buruli ulcer: the TREAT-BU Trial

Authors
Category Primary study
ConferenceAnnual Meeting of the Infectious Diseases Society of America, ID Week 2025
Year 2026
This article has no abstract
Epistemonikos ID: 548fe95373de3918cc617d97d12cd1fb100ab5b8
First added on: Mar 21, 2026